Skip to main content

Chembio Diagnostics, Inc.

CEMIDelisted Apr 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001092662

Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Chembio Diagnostics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CEMI: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6047−13
Shares4.85M3.97M−875.9K (−18.1%)
Value$14.4M$9.94M−$4.47M (−31.0%)

New holders (8)

Institutions that held Chembio Diagnostics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CEMI in Q3 2021
InstitutionSharesValue% of portfolio
Susquehanna Fundamental Investments, LLC179,680$449.0K0.01%
Group One Trading, L.P.70,601$177.0K0.00%
Wolverine Trading, LLC22,770$57.0K0.00%
Signaturefd, LLC20,000$50.0K0.00%
Virtu Financial LLC19,653$49.0K0.00%
NEXT Financial Group, Inc6,000$15.0K0.00%
Antonetti Capital Management LLC2,000$5.00K0.00%
Focused Wealth Management, Inc375$1.00K0.00%

Sold out (21)

Institutions that held Chembio Diagnostics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.